SIMPLEX TRADING, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D908. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$1,664
-7.7%
46,700
+19.4%
0.00%0.0%
Q2 2023$1,803
+117.2%
39,100
+88.9%
0.00%0.0%
Q1 2023$830
+149.2%
20,700
+187.5%
0.00%
Q4 2022$333
-99.9%
7,200
-41.5%
0.00%
-100.0%
Q3 2022$509,000
+2894.1%
12,300
+4000.0%
0.00%
Q2 2022$17,000
+21.4%
300
+50.0%
0.00%
Q1 2022$14,000
-75.0%
200
-66.7%
0.00%
Q3 2021$56,000
-1.8%
6000.0%0.00%
Q2 2021$57,000
-95.1%
600
+482.5%
0.00%
-100.0%
Q1 2021$1,172,000
-21.6%
103
-4.6%
0.00%0.0%
Q4 2020$1,495,000
+9243.8%
108
+5300.0%
0.00%
Q3 2020$16,000
-96.6%
2
-96.7%
0.00%
-100.0%
Q2 2020$469,000
+221.2%
60
+81.8%
0.00%
Q1 2020$146,000
-36.5%
33
-38.9%
0.00%
-100.0%
Q4 2019$230,000
+995.2%
54
+980.0%
0.00%
Q3 2019$21,000
-63.2%
5
-44.4%
0.00%
Q2 2019$57,000
+18.8%
9
+28.6%
0.00%
Q1 2019$48,000
-57.9%
7
-53.3%
0.00%
Q3 2018$114,000
-0.9%
150.0%0.00%
Q2 2018$115,000
+666.7%
15
+25.0%
0.00%
-100.0%
Q1 2018$15,000
+650.0%
12
-25.0%
0.00%
Q4 2017$2,000
-87.5%
16
-89.0%
0.00%
-100.0%
Q3 2017$16,000
-5.9%
145
+52.6%
0.00%0.0%
Q2 2017$17,000
+6.2%
95
-3.1%
0.00%0.0%
Q1 2017$16,000
-11.1%
98
+81.5%
0.00%0.0%
Q4 2016$18,000
+157.1%
54
+575.0%
0.00%
Q3 2016$7,000
+600.0%
8
-82.2%
0.00%
Q2 2016$1,0000.0%45
+55.2%
0.00%
Q1 2016$1,000
-94.4%
29
+16.0%
0.00%
-100.0%
Q4 2015$18,0000.0%25
-35.9%
0.00%0.0%
Q3 2015$18,000
-79.8%
39
-13.3%
0.00%
-85.7%
Q2 2015$89,000
+2866.7%
45
+650.0%
0.01%
Q1 2015$3,0006
+20.0%
0.00%
Q4 2014$050.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 46,700$1,6640.00%
GROUP ONE TRADING, L.P. 1,600$57,0400.00%
JANE STREET GROUP, LLC 15,800$563,2700.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders